Literature DB >> 23079664

SnapShot: breast cancer.

Kornelia Polyak1, Otto Metzger Filho.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23079664     DOI： 10.1016/j.ccr.2012.06.021

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  35 in total

Review 1.  Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review.

Authors:  Priyanka Singh; Veerandra Kumar; Sonu Kumar Gupta; Gudia Kumari; Malkhey Verma
Journal:  Med Oncol       Date:  2021-01-16       Impact factor: 3.064

2.  LMO4 mediates trastuzumab resistance in HER2 positive breast cancer cells.

Authors:  Keshuo Ding; Zhengsheng Wu; Xiaocan Li; Youjing Sheng; Xiaonan Wang; Sheng Tan
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

3.  PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses.

Authors:  Jiqing Sai; Philip Owens; Sergey V Novitskiy; Oriana E Hawkins; Anna E Vilgelm; Jinming Yang; Tammy Sobolik; Nicole Lavender; Andrew C Johnson; Colt McClain; Gregory D Ayers; Mark C Kelley; Melinda Sanders; Ingrid A Mayer; Harold L Moses; Mark Boothby; Ann Richmond
Journal:  Clin Cancer Res       Date:  2016-12-21       Impact factor: 12.531

Review 4.  Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.

Authors:  Daniel G Stover; Nikhil Wagle
Journal:  Curr Oncol Rep       Date:  2015-04       Impact factor: 5.075

5.  Oncogenic PIK3CA mutations increase dependency on the mRNA cap methyltransferase, RNMT, in breast cancer cells.

Authors:  Sianadh Dunn; Olivia Lombardi; Radoslaw Lukoszek; Victoria H Cowling
Journal:  Open Biol       Date:  2019-04-26       Impact factor: 6.411

6.  Protein C receptor stimulates multiple signaling pathways in breast cancer cells.

Authors:  Daisong Wang; Chunye Liu; Jingqiang Wang; Yingying Jia; Xin Hu; Hai Jiang; Zhi-Ming Shao; Yi Arial Zeng
Journal:  J Biol Chem       Date:  2017-12-07       Impact factor: 5.157

7.  JARID1B is a luminal lineage-driving oncogene in breast cancer.

Authors:  Shoji Yamamoto; Zhenhua Wu; Hege G Russnes; Shinji Takagi; Guillermo Peluffo; Charles Vaske; Xi Zhao; Hans Kristian Moen Vollan; Reo Maruyama; Muhammad B Ekram; Hanfei Sun; Jee Hyun Kim; Kristopher Carver; Mattia Zucca; Jianxing Feng; Vanessa Almendro; Marina Bessarabova; Oscar M Rueda; Yuri Nikolsky; Carlos Caldas; X Shirley Liu; Kornelia Polyak
Journal:  Cancer Cell       Date:  2014-06-16       Impact factor: 31.743

8.  PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion.

Authors:  Hamid H Gari; Gregory D DeGala; Rahul Ray; M Scott Lucia; James R Lambert
Journal:  Cancer Lett       Date:  2016-07-21       Impact factor: 8.679

9.  Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy.

Authors:  Carly Bess Williams; Caroline A Nebhan; Jinming Yang; Lauren S Starnes; Chi Yan; Anna E Vilgelm; Sheau-Chiann Chen; Gregory Dan Ayers; Vandana Abramson; Ingrid A Mayer; Ann Richmond
Journal:  Breast Cancer Res Treat       Date:  2020-08-07       Impact factor: 4.872

10.  Modeling Breast Cancer Using CRISPR-Cas9-Mediated Engineering of Human Breast Organoids.

Authors:  Johanna F Dekkers; James R Whittle; François Vaillant; Huei-Rong Chen; Caleb Dawson; Kevin Liu; Maarten H Geurts; Marco J Herold; Hans Clevers; Geoffrey J Lindeman; Jane E Visvader
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.